BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2306 related articles for article (PubMed ID: 15864352)

  • 1. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.
    Donnelly KL; Smith CI; Schwarzenberg SJ; Jessurun J; Boldt MD; Parks EJ
    J Clin Invest; 2005 May; 115(5):1343-51. PubMed ID: 15864352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis.
    Lee JJ; Lambert JE; Hovhannisyan Y; Ramos-Roman MA; Trombold JR; Wagner DA; Parks EJ
    Am J Clin Nutr; 2015 Jan; 101(1):34-43. PubMed ID: 25527748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A meal high in saturated fat evokes postprandial dyslipemia, hyperinsulinemia, and altered lipoprotein expression in obese children with and without nonalcoholic fatty liver disease.
    Mager DR; Mazurak V; Rodriguez-Dimitrescu C; Vine D; Jetha M; Ball G; Yap J
    JPEN J Parenter Enteral Nutr; 2013 Jul; 37(4):517-28. PubMed ID: 23223552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease.
    Fabbrini E; Mohammed BS; Magkos F; Korenblat KM; Patterson BW; Klein S
    Gastroenterology; 2008 Feb; 134(2):424-31. PubMed ID: 18242210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Fructose Feeding on Intestinal Triacylglycerol Production and De Novo Fatty Acid Synthesis in Humans.
    Steenson S; Shojaee-Moradie F; B Whyte M; G Jackson K; Lovegrove JA; A Fielding B; Umpleby AM
    Nutrients; 2020 Jun; 12(6):. PubMed ID: 32549314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease.
    Tamura S; Shimomura I
    J Clin Invest; 2005 May; 115(5):1139-42. PubMed ID: 15864343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of liver fat on the differential partitioning of hepatic triacylglycerol into VLDL subclasses on high and low sugar diets.
    Umpleby AM; Shojaee-Moradie F; Fielding B; Li X; Marino A; Alsini N; Isherwood C; Jackson N; Ahmad A; Stolinski M; Lovegrove JA; Johnsen S; Jeewaka R Mendis AS; Wright J; Wilinska ME; Hovorka R; Bell JD; Thomas EL; Frost GS; Griffin BA
    Clin Sci (Lond); 2017 Nov; 131(21):2561-2573. PubMed ID: 28923880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states.
    Barrows BR; Parks EJ
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1446-52. PubMed ID: 16449340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex-Specific Differences in Hepatic Fat Oxidation and Synthesis May Explain the Higher Propensity for NAFLD in Men.
    Pramfalk C; Pavlides M; Banerjee R; McNeil CA; Neubauer S; Karpe F; Hodson L
    J Clin Endocrinol Metab; 2015 Dec; 100(12):4425-33. PubMed ID: 26414963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased dietary substrate delivery alters hepatic fatty acid recycling in healthy men.
    Timlin MT; Barrows BR; Parks EJ
    Diabetes; 2005 Sep; 54(9):2694-701. PubMed ID: 16123359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver specific inactivation of carboxylesterase 3/triacylglycerol hydrolase decreases blood lipids without causing severe steatosis in mice.
    Lian J; Wei E; Wang SP; Quiroga AD; Li L; Di Pardo A; van der Veen J; Sipione S; Mitchell GA; Lehner R
    Hepatology; 2012 Dec; 56(6):2154-62. PubMed ID: 22707181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isotope Labeling and Biochemical Assessment of Liver-Triacylglycerol in Patients with Different Levels of Histologically-Graded Liver Disease.
    Syed-Abdul MM; Moore MP; Wheeler AA; Ganga RR; Diaz-Arias A; Petroski GF; Rector RS; Ibdah JA; Parks EJ
    J Nutr; 2023 Dec; 153(12):3418-3429. PubMed ID: 37774841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A lipidomic analysis of nonalcoholic fatty liver disease.
    Puri P; Baillie RA; Wiest MM; Mirshahi F; Choudhury J; Cheung O; Sargeant C; Contos MJ; Sanyal AJ
    Hepatology; 2007 Oct; 46(4):1081-90. PubMed ID: 17654743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using total plasma triacylglycerol to assess hepatic
    Hodson L; Parry SA; Cornfield T; Charlton C; Low WS; Green CJ; Rosqvist F
    Ups J Med Sci; 2020 Aug; 125(3):211-216. PubMed ID: 32208800
    [No Abstract]   [Full Text] [Related]  

  • 16. Spillover of dietary fatty acids and use of serum nonesterified fatty acids for the synthesis of VLDL-triacylglycerol under two different feeding regimens.
    Barrows BR; Timlin MT; Parks EJ
    Diabetes; 2005 Sep; 54(9):2668-73. PubMed ID: 16123356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High hepatic SCD1 activity is associated with low liver fat content in healthy subjects under a lipogenic diet.
    Silbernagel G; Kovarova M; Cegan A; Machann J; Schick F; Lehmann R; Häring HU; Stefan N; Schleicher E; Fritsche A; Peter A
    J Clin Endocrinol Metab; 2012 Dec; 97(12):E2288-92. PubMed ID: 23015656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease.
    Paglialunga S; Dehn CA
    Lipids Health Dis; 2016 Sep; 15(1):159. PubMed ID: 27640119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated de novo lipogenesis, slow liver triglyceride turnover, and clinical correlations in nonalcoholic steatohepatitis patients.
    Lawitz EJ; Li KW; Nyangau E; Field TJ; Chuang JC; Billin A; Wang L; Wang Y; Huss RS; Chung C; Subramanian GM; Myers RP; Hellerstein MK
    J Lipid Res; 2022 Sep; 63(9):100250. PubMed ID: 35835205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic adaptations to dietary fat malabsorption in chylomicron-deficient mice.
    Jung HR; Turner SM; Neese RA; Young SG; Hellerstein MK
    Biochem J; 1999 Oct; 343 Pt 2(Pt 2):473-8. PubMed ID: 10510316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 116.